• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EphrinA3 是肺腺癌中恶性行为的关键调节因子和潜在的预后因素。

EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma.

机构信息

Department of Pulmonary and Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, China.

出版信息

Cancer Med. 2023 Jan;12(2):1630-1642. doi: 10.1002/cam4.4987. Epub 2022 Jun 30.

DOI:10.1002/cam4.4987
PMID:35770949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9883548/
Abstract

BACKGROUND

As a member of the Ephrin protein family that elicits short distance cell-cell signaling, EphrinA3 has been shown to promote or inhibit tumorigenesis depending on tumor types, but its roles and the underlying mechanisms in lung adenocarcinoma (LUAD) have not been reported.

MATERIALS AND METHODS

The TCGA database and Kaplan-Meier Plotter database were used to analyze the differential expression of EphrinA3 between LUAD and para-carcinoma tissues, and its effect on overall survival of LUAD patients. CCK-8 assay, Edu assay, and flow cytometry were used to probe the effect of EphrinA3 on the proliferation of LUAD cells, and transwell assay was employed to examine its effect on migration and invasion. In addition, the effect of EphrinA3 on the growth of LUAD was further evaluated using a xenograft tumor model.

RESULTS

EphrinA3 was expressed highly in LUAD, and its expression level was negatively correlated with the prognosis of LUAD patients. In addition, EphrinA3 promoted proliferation, migration, and invasion of LUAD cells, and accelerated tumor growth in a xenograft LUAD model. The reported EphrinA3 receptors, EphA1 and EphA10, were expressed in clinical LUAD tissues and co-localized with EphrinA3 in LUAD cells. Mechanistically, EphrinA3/Eph signaling activated AKT, ERK, and p38MAPK, induced epithelial-mesenchymal transition (EMT), and upregulated matrix metalloproteases-2 and -9 (MMP-2/-9).

CONCLUSION

EphrinA3 expression was negatively correlated with prognosis of patients with LUAD. EphrinA3 promoted proliferation, migration, and invasion of LUAD cells. EphrinA3 enhanced the phosphorylation of ERK and AKT, and potentiates EMT and MMP expression in LUAD cells.

摘要

背景

作为 Ephrin 蛋白家族的一员,EphrinA3 通过短程细胞-细胞信号传递发挥作用,其在不同肿瘤类型中促进或抑制肿瘤发生的作用尚不一致,但 EphrinA3 在肺腺癌(LUAD)中的作用及其潜在机制尚未见报道。

材料和方法

TCGA 数据库和 Kaplan-Meier Plotter 数据库用于分析 LUAD 和癌旁组织中 EphrinA3 的差异表达及其对 LUAD 患者总生存期的影响。CCK-8 检测、Edu 检测和流式细胞术用于探讨 EphrinA3 对 LUAD 细胞增殖的影响,Transwell 检测用于检测其对迁移和侵袭的影响。此外,还使用异种移植 LUAD 模型进一步评估 EphrinA3 对 LUAD 生长的影响。

结果

EphrinA3 在 LUAD 中高表达,其表达水平与 LUAD 患者的预后呈负相关。此外,EphrinA3 促进 LUAD 细胞的增殖、迁移和侵袭,并加速异种移植 LUAD 模型中的肿瘤生长。报道的 EphrinA3 受体 EphA1 和 EphA10 在临床 LUAD 组织中表达,并与 LUAD 细胞中的 EphrinA3 共定位。在机制上,EphrinA3/Eph 信号激活 AKT、ERK 和 p38MAPK,诱导上皮-间充质转化(EMT),并上调基质金属蛋白酶-2 和 -9(MMP-2/-9)。

结论

EphrinA3 的表达与 LUAD 患者的预后呈负相关。EphrinA3 促进 LUAD 细胞的增殖、迁移和侵袭。EphrinA3 增强 ERK 和 AKT 的磷酸化,增强 LUAD 细胞中的 EMT 和 MMP 表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/4ae017ab87d9/CAM4-12-1630-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/fe4dd918e015/CAM4-12-1630-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/b6c5b1667709/CAM4-12-1630-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/748fb9b56435/CAM4-12-1630-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/3070df9082d8/CAM4-12-1630-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/e2da9b08a768/CAM4-12-1630-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/4ae017ab87d9/CAM4-12-1630-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/fe4dd918e015/CAM4-12-1630-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/b6c5b1667709/CAM4-12-1630-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/748fb9b56435/CAM4-12-1630-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/3070df9082d8/CAM4-12-1630-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/e2da9b08a768/CAM4-12-1630-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ea/9883548/4ae017ab87d9/CAM4-12-1630-g001.jpg

相似文献

1
EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma.EphrinA3 是肺腺癌中恶性行为的关键调节因子和潜在的预后因素。
Cancer Med. 2023 Jan;12(2):1630-1642. doi: 10.1002/cam4.4987. Epub 2022 Jun 30.
2
EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma.EphA10 通过调节肺腺癌中的 MAPK/ERK 级联反应驱动肿瘤进展和免疫逃逸。
Int Immunopharmacol. 2022 Sep;110:109031. doi: 10.1016/j.intimp.2022.109031. Epub 2022 Jul 12.
3
Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.致癌锌指蛋白 ZNF687 通过激活 PI3K/AKT 信号通路加速肺腺癌细胞增殖和肿瘤进展。
Thorac Cancer. 2023 May;14(14):1223-1238. doi: 10.1111/1759-7714.14856. Epub 2023 Mar 21.
4
FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.FAM83B 通过 PI3K/AKT/NF-κB 通路促进原发性肺腺癌的侵袭。
BMC Pulm Med. 2023 Jan 23;23(1):32. doi: 10.1186/s12890-022-02303-5.
5
Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.胍氨酸酶通过激活 NO-MAPKs-PI3K/Akt 通路促进肺腺癌细胞肿瘤发生。
Cell Death Dis. 2019 Nov 7;10(11):854. doi: 10.1038/s41419-019-2082-3.
6
SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.SLC39A5 通过激活 PI3K/AKT 信号促进肺腺癌细胞增殖。
Pathol Res Pract. 2021 Aug;224:153541. doi: 10.1016/j.prp.2021.153541. Epub 2021 Jul 3.
7
Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis.Discoidin domain receptor 1 通过 AKT/snail 信号轴促进肺腺癌迁移。
Mol Biol Rep. 2022 Aug;49(8):7275-7286. doi: 10.1007/s11033-022-07509-8. Epub 2022 May 13.
8
PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25.PLEK2通过上调SPC25激活PI3K/AKT信号通路,以驱动肺腺癌进展。
Cell Biol Int. 2024 Sep;48(9):1285-1300. doi: 10.1002/cbin.12197. Epub 2024 Jun 18.
9
Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.RCC2 的过表达通过诱导上皮-间充质转化增强肺腺癌细胞的迁移能力并促进肿瘤转移。
Clin Cancer Res. 2017 Sep 15;23(18):5598-5610. doi: 10.1158/1078-0432.CCR-16-2909. Epub 2017 Jun 12.
10
Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway.矢车菊素-3-葡萄糖苷通过下调 TP53I3 和抑制 PI3K/AKT/mTOR 通路抑制肺腺癌的进展。
World J Surg Oncol. 2021 Aug 6;19(1):232. doi: 10.1186/s12957-021-02339-7.

引用本文的文献

1
Downregulation of DIP2B as a prognostic marker inhibited cancer proliferation and migration and was associated with immune infiltration in lung adenocarcinoma via CCND1 and MMP2.作为一种预后标志物,DIP2B的下调通过CCND1和MMP2抑制肺腺癌的增殖和迁移,并与免疫浸润相关。
Heliyon. 2024 May 28;10(12):e32025. doi: 10.1016/j.heliyon.2024.e32025. eCollection 2024 Jun 30.
2
PI3K/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells.PI3K/AKT信号通路作为肺肿瘤细胞上皮-间质转化的关键调节因子。
Cancer Cell Int. 2024 May 10;24(1):165. doi: 10.1186/s12935-024-03357-7.
3
Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway.

本文引用的文献

1
EphA8 inhibits cell apoptosis via AKT signaling and is associated with poor prognosis in breast cancer.EphA8通过AKT信号传导抑制细胞凋亡,并与乳腺癌的不良预后相关。
Oncol Rep. 2021 Aug;46(2). doi: 10.3892/or.2021.8134. Epub 2021 Jul 19.
2
Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells.Ephrin A4-ephrin receptor A10 信号通过上调口腔鳞状细胞癌细胞中 NANOG 的表达促进细胞迁移和球体形成。
Sci Rep. 2021 Jan 12;11(1):644. doi: 10.1038/s41598-020-80060-3.
3
Cancer Statistics, 2021.
青蒿琥酯通过抑制 Stat3/Akt 信号通路抑制 EFNA3 从而抑制脉络膜黑色素瘤的发生。
J Cancer Res Clin Oncol. 2024 Apr 17;150(4):202. doi: 10.1007/s00432-024-05711-8.
4
Extracellular vesicles derived from human umbilical cord mesenchymal stem cells stimulate angiogenesis in myocardial infarction via the microRNA-423-5p/EFNA3 axis.人脐带间充质干细胞衍生的细胞外囊泡通过微小RNA-423-5p/EFNA3轴刺激心肌梗死中的血管生成。
Postepy Kardiol Interwencyjnej. 2022 Dec;18(4):373-391. doi: 10.5114/aic.2023.124797. Epub 2023 Feb 2.
5
May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?EPH/Ephrin 靶向治疗会给肺癌治疗带来变革吗?
Int J Mol Sci. 2022 Dec 21;24(1):93. doi: 10.3390/ijms24010093.
癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
4
OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.口腔鳞状细胞癌外泌体通过 PI3K/AKT 通路调节 miR-210-3p 靶向 EFNA3 促进口腔癌血管生成。
Biomed Res Int. 2020 Jul 8;2020:2125656. doi: 10.1155/2020/2125656. eCollection 2020.
5
The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells.催化缺陷型受体蛋白酪氨酸激酶EphA10促进胰腺癌细胞的肿瘤发生。
Cancer Sci. 2020 Sep;111(9):3292-3302. doi: 10.1111/cas.14568. Epub 2020 Jul 27.
6
MiR-210-3p-EphrinA3-PI3K/AKT axis regulates the progression of oral cancer.miR-210-3p-EphrinA3-PI3K/AKT 轴调控口腔癌的进展。
J Cell Mol Med. 2020 Apr;24(7):4011-4022. doi: 10.1111/jcmm.15036. Epub 2020 Mar 17.
7
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.C1GALT1 与不良预后相关,并通过激活胃癌中的 Ephrin A1 介导的细胞迁移 EPHA2 促进可溶性 Ephrin A1 的迁移。
Oncogene. 2020 Mar;39(13):2724-2740. doi: 10.1038/s41388-020-1178-7. Epub 2020 Jan 31.
8
Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity.Eph 受体和 Ephrin 配体在免疫中的新兴作用。
Front Immunol. 2019 Jul 4;10:1473. doi: 10.3389/fimmu.2019.01473. eCollection 2019.
9
EphA8 acts as an oncogene and contributes to poor prognosis in gastric cancer via regulation of ADAM10.EphA8 通过调节 ADAM10 作为癌基因促进胃癌不良预后。
J Cell Physiol. 2019 Nov;234(11):20408-20419. doi: 10.1002/jcp.28642. Epub 2019 Apr 26.
10
The RTK Interactome: Overview and Perspective on RTK Heterointeractions.RTK 相互作用组:RTK 异源相互作用的概述和展望。
Chem Rev. 2019 May 8;119(9):5881-5921. doi: 10.1021/acs.chemrev.8b00467. Epub 2018 Dec 27.